BR9708859A - Composto uso do mesmo composição para inibir formação de trombo em sangue e processos para inibir trombina e formação de agregados de plaquetas sanguíneas e de trombo no sangue para tratar ou evitar tromboemolismo venoso e embolismo pulmonar trombose tromboembolismo cardiogênico acidente vascular cerebral trombose angina instável infartação miocárdica aterosclerose distúrbio cardaco isquêmico reoclus o restenose oclus o de enxertos de derivação de artéria coronária e doença cerebrovascular oclus - Google Patents
Composto uso do mesmo composição para inibir formação de trombo em sangue e processos para inibir trombina e formação de agregados de plaquetas sanguíneas e de trombo no sangue para tratar ou evitar tromboemolismo venoso e embolismo pulmonar trombose tromboembolismo cardiogênico acidente vascular cerebral trombose angina instável infartação miocárdica aterosclerose distúrbio cardaco isquêmico reoclus o restenose oclus o de enxertos de derivação de artéria coronária e doença cerebrovascular oclusInfo
- Publication number
- BR9708859A BR9708859A BR9708859A BR9708859A BR9708859A BR 9708859 A BR9708859 A BR 9708859A BR 9708859 A BR9708859 A BR 9708859A BR 9708859 A BR9708859 A BR 9708859A BR 9708859 A BR9708859 A BR 9708859A
- Authority
- BR
- Brazil
- Prior art keywords
- thrombus formation
- blood
- inhibit
- thromboemolism
- reocclusion
- Prior art date
Links
- 108090000190 Thrombin Proteins 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229960004072 thrombin Drugs 0.000 title abstract 2
- 208000007536 Thrombosis Diseases 0.000 title 3
- 230000015572 biosynthetic process Effects 0.000 title 2
- 210000004369 blood Anatomy 0.000 title 2
- 239000008280 blood Substances 0.000 title 2
- 206010002388 Angina unstable Diseases 0.000 title 1
- 201000001320 Atherosclerosis Diseases 0.000 title 1
- 208000020446 Cardiac disease Diseases 0.000 title 1
- 208000005189 Embolism Diseases 0.000 title 1
- 208000010378 Pulmonary Embolism Diseases 0.000 title 1
- 206010038563 Reocclusion Diseases 0.000 title 1
- 208000001435 Thromboembolism Diseases 0.000 title 1
- 208000007814 Unstable Angina Diseases 0.000 title 1
- 210000001772 blood platelet Anatomy 0.000 title 1
- 230000001269 cardiogenic effect Effects 0.000 title 1
- 208000026106 cerebrovascular disease Diseases 0.000 title 1
- 210000004351 coronary vessel Anatomy 0.000 title 1
- 208000019622 heart disease Diseases 0.000 title 1
- 201000004332 intermediate coronary syndrome Diseases 0.000 title 1
- 230000000302 ischemic effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 208000010125 myocardial infarction Diseases 0.000 title 1
- 208000037803 restenosis Diseases 0.000 title 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001732 thrombotic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1604196P | 1996-04-23 | 1996-04-23 | |
| GBGB9609714.2A GB9609714D0 (en) | 1996-05-09 | 1996-05-09 | Pyridinone thrombin inhibitors |
| US4300997P | 1997-04-14 | 1997-04-14 | |
| PCT/US1997/006744 WO1997040024A1 (en) | 1996-04-23 | 1997-04-18 | Pyrazinone thrombin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9708859A true BR9708859A (pt) | 1999-08-03 |
Family
ID=27268274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9708859A BR9708859A (pt) | 1996-04-23 | 1997-04-18 | Composto uso do mesmo composição para inibir formação de trombo em sangue e processos para inibir trombina e formação de agregados de plaquetas sanguíneas e de trombo no sangue para tratar ou evitar tromboemolismo venoso e embolismo pulmonar trombose tromboembolismo cardiogênico acidente vascular cerebral trombose angina instável infartação miocárdica aterosclerose distúrbio cardaco isquêmico reoclus o restenose oclus o de enxertos de derivação de artéria coronária e doença cerebrovascular oclus |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0900207B1 (pt) |
| JP (1) | JP3140790B2 (pt) |
| KR (1) | KR20000010650A (pt) |
| AT (1) | ATE209191T1 (pt) |
| AU (1) | AU714985B2 (pt) |
| BG (1) | BG102948A (pt) |
| BR (1) | BR9708859A (pt) |
| CA (1) | CA2252964A1 (pt) |
| CZ (1) | CZ340898A3 (pt) |
| DE (1) | DE69709727T2 (pt) |
| EE (1) | EE9800353A (pt) |
| HR (1) | HRP970211A2 (pt) |
| IL (1) | IL126404A0 (pt) |
| IS (1) | IS4853A (pt) |
| NO (1) | NO984928L (pt) |
| NZ (1) | NZ331993A (pt) |
| PE (1) | PE13399A1 (pt) |
| PL (1) | PL329441A1 (pt) |
| SK (1) | SK145398A3 (pt) |
| TR (1) | TR199802133T2 (pt) |
| WO (1) | WO1997040024A1 (pt) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU746024B2 (en) * | 1996-04-23 | 2002-04-11 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| EP0927171B1 (en) * | 1996-09-16 | 2002-02-20 | Du Pont Pharmaceuticals Company | Pyrazinones and triazinones and their derivatives thereof |
| JP2001518932A (ja) * | 1997-03-24 | 2001-10-16 | メルク エンド カンパニー インコーポレーテッド | トロンビン阻害薬 |
| US6011038A (en) * | 1997-09-05 | 2000-01-04 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| AU753479B2 (en) * | 1998-05-19 | 2002-10-17 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| US6147078A (en) * | 1998-05-19 | 2000-11-14 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| JP2002516326A (ja) * | 1998-05-26 | 2002-06-04 | メルク エンド カムパニー インコーポレーテッド | イミダゾピリジン系トロンビン阻害薬 |
| EP1589029B1 (en) | 1998-06-11 | 2010-03-17 | Ortho-McNeil Pharmaceuticals, Inc. | Pyrazinone protease inhibitors |
| DK0997474T3 (da) * | 1998-08-14 | 2004-02-09 | Pfizer | Antithrombotiske midler |
| CA2343109A1 (en) * | 1998-09-28 | 2000-04-06 | Merck & Co., Inc. | Thrombin inhibitors |
| JP2002528542A (ja) | 1998-10-30 | 2002-09-03 | メルク エンド カムパニー インコーポレーテッド | トロンビン阻害剤 |
| AU747776B2 (en) | 1998-10-30 | 2002-05-23 | Merck & Co., Inc. | Thrombin inhibitors |
| WO2000038683A1 (en) | 1998-12-23 | 2000-07-06 | Du Pont Pharmaceuticals Company | THROMBIN OR FACTOR Xa INHIBITORS |
| AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
| US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| EP1202975B1 (en) * | 1999-05-19 | 2005-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| EP1586565A1 (en) * | 1999-05-19 | 2005-10-19 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| US6664255B1 (en) * | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| US6458952B1 (en) | 1999-05-19 | 2002-10-01 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US6653316B1 (en) | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| UA58636C2 (uk) * | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням |
| JP4749640B2 (ja) | 1999-07-19 | 2011-08-17 | メルク フロスト カナダ リミテツド | ピラジノン、このような化合物を含む組成物 |
| CA2391012A1 (en) * | 1999-11-23 | 2001-05-31 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| AU2001243598A1 (en) | 2000-03-13 | 2001-09-24 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
| AU2001245856A1 (en) | 2000-03-23 | 2001-10-03 | Merck & Co., Inc. | Thrombin inhibitors |
| CA2405306A1 (en) | 2000-04-05 | 2001-10-18 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| AU2001249870A1 (en) | 2000-04-05 | 2001-10-23 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| US6506761B1 (en) | 2000-04-14 | 2003-01-14 | Corvas International, Inc. | Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| AU2001255410A1 (en) * | 2000-04-14 | 2001-10-30 | Corvas International, Inc. | Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| US6506760B1 (en) | 2000-04-14 | 2003-01-14 | Corvas International, Inc. | Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| US6686484B2 (en) | 2000-04-17 | 2004-02-03 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| CA2415932A1 (en) | 2000-07-17 | 2002-01-24 | 3-Dimensional Pharmaceuticals, Inc. | Cyclic oxyguanidine pyrazinones as protease inhibitors |
| US6710058B2 (en) | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| EP1351686A2 (en) | 2000-11-20 | 2003-10-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
| US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
| CA2462305A1 (en) | 2001-10-03 | 2003-04-10 | Michael S. South | 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| BR0213099A (pt) | 2001-10-03 | 2004-10-19 | Pharmacia Corp | Compostos policìclicos de 5 membros substituìdos úteis para inibição seletiva da cascata de coagulação |
| AP1822A (en) | 2002-02-14 | 2008-01-30 | Pharmacia Corp | Substituted pyridinones as modulators of P38 MAP kinase. |
| GB0306615D0 (en) * | 2003-03-22 | 2003-04-30 | Astrazeneca Ab | New use |
| EP1526131A1 (en) * | 2003-10-22 | 2005-04-27 | Graffinity Pharmaceuticals Aktiengesellschaft | Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors |
| GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| JP2008546684A (ja) * | 2005-06-17 | 2008-12-25 | アストラゼネカ アクチボラグ | トロンビン阻害性２−オキソ−１，２，５，６−テトラヒドロピリジン誘導体 |
| WO2017067670A1 (en) | 2015-10-23 | 2017-04-27 | Pharmathen S.A. | A novel process for the preparation of tryptamines and derivatives thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0262096B1 (de) * | 1986-09-26 | 1992-01-02 | Ciba-Geigy Ag | Aminopyrazinone und Aminotriazinone |
-
1997
- 1997-04-18 EE EE9800353A patent/EE9800353A/xx unknown
- 1997-04-18 SK SK1453-98A patent/SK145398A3/sk unknown
- 1997-04-18 EP EP97918780A patent/EP0900207B1/en not_active Expired - Lifetime
- 1997-04-18 CZ CZ983408A patent/CZ340898A3/cs unknown
- 1997-04-18 TR TR1998/02133T patent/TR199802133T2/xx unknown
- 1997-04-18 BR BR9708859A patent/BR9708859A/pt not_active Application Discontinuation
- 1997-04-18 JP JP09538296A patent/JP3140790B2/ja not_active Expired - Fee Related
- 1997-04-18 IL IL12640497A patent/IL126404A0/xx unknown
- 1997-04-18 PL PL97329441A patent/PL329441A1/xx unknown
- 1997-04-18 NZ NZ331993A patent/NZ331993A/xx unknown
- 1997-04-18 DE DE69709727T patent/DE69709727T2/de not_active Expired - Fee Related
- 1997-04-18 AU AU26799/97A patent/AU714985B2/en not_active Ceased
- 1997-04-18 AT AT97918780T patent/ATE209191T1/de active
- 1997-04-18 CA CA002252964A patent/CA2252964A1/en not_active Abandoned
- 1997-04-18 KR KR1019980708609A patent/KR20000010650A/ko not_active Withdrawn
- 1997-04-18 WO PCT/US1997/006744 patent/WO1997040024A1/en not_active Ceased
- 1997-04-21 HR HR60/043,009A patent/HRP970211A2/xx not_active Application Discontinuation
- 1997-04-23 PE PE1997000308A patent/PE13399A1/es not_active Application Discontinuation
-
1998
- 1998-09-25 IS IS4853A patent/IS4853A/is unknown
- 1998-10-22 NO NO984928A patent/NO984928L/no unknown
- 1998-11-23 BG BG102948A patent/BG102948A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0900207B1 (en) | 2001-11-21 |
| EP0900207A1 (en) | 1999-03-10 |
| BG102948A (bg) | 1999-11-30 |
| DE69709727D1 (de) | 2002-02-21 |
| JP3140790B2 (ja) | 2001-03-05 |
| AU714985B2 (en) | 2000-01-13 |
| HRP970211A2 (en) | 1998-06-30 |
| IS4853A (is) | 1998-09-25 |
| NZ331993A (en) | 2000-04-28 |
| WO1997040024A1 (en) | 1997-10-30 |
| SK145398A3 (en) | 1999-05-07 |
| PL329441A1 (en) | 1999-03-29 |
| CA2252964A1 (en) | 1997-10-30 |
| AU2679997A (en) | 1997-11-12 |
| ATE209191T1 (de) | 2001-12-15 |
| NO984928L (no) | 1998-12-22 |
| DE69709727T2 (de) | 2002-08-08 |
| CZ340898A3 (cs) | 1999-02-17 |
| EE9800353A (et) | 1999-04-15 |
| TR199802133T2 (xx) | 2000-09-21 |
| IL126404A0 (en) | 1999-05-09 |
| KR20000010650A (ko) | 2000-02-25 |
| JP2000508334A (ja) | 2000-07-04 |
| NO984928D0 (no) | 1998-10-22 |
| PE13399A1 (es) | 1999-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9708859A (pt) | Composto uso do mesmo composição para inibir formação de trombo em sangue e processos para inibir trombina e formação de agregados de plaquetas sanguíneas e de trombo no sangue para tratar ou evitar tromboemolismo venoso e embolismo pulmonar trombose tromboembolismo cardiogênico acidente vascular cerebral trombose angina instável infartação miocárdica aterosclerose distúrbio cardaco isquêmico reoclus o restenose oclus o de enxertos de derivação de artéria coronária e doença cerebrovascular oclus | |
| NO972892L (no) | Bicykliske lavmolekylvekts-trombin-inhibitorer | |
| WO2001074793A3 (en) | Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1 | |
| CA2217054A1 (en) | Compositions and methods for inhibiting thrombogenesis | |
| NO953672L (no) | Fenoksyfenyleddiksyrederivater | |
| Abendschein et al. | Maintenance of coronary patency after fibrinolysis with tissue factor pathway inhibitor | |
| RU94046070A (ru) | Применение /(4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил)гидразоно/ пропандинитрила для лечения или профилактики ишемии миокарда, способ лечения ишемии миокарда | |
| GB9606881D0 (en) | Compositions for inhibiting thrombogenesis | |
| ES2104909T3 (es) | Nuevos derivados de heparina y proceso para la preparacion de los mismos. | |
| WO1998012329A3 (en) | Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin | |
| Afosah et al. | Factor IX (a) inhibitors: an updated patent review (2003-present) | |
| TR200103491T2 (tr) | Pirazinon trombin inhibitörleri. | |
| TR200100901T2 (tr) | Kateter-bazında revaskülarizasyonu önleme veya geciktirme yöntemi | |
| DK0812205T3 (da) | Antithrombotiske azacycloalkylalkanoylpeptider og -pseudopeptider | |
| HU892304D0 (en) | Preparation and process for quick desintegration of thrombi | |
| ATE498305T1 (de) | Vermeidung und behandlung von krankheiten, die mit der blutgerinnung in zusammenhang stehen | |
| Eisenberg | Role of new anticoagulants as adjunctive therapy during thrombolysis | |
| Phillips et al. | Glycoprotein IIb-IIIa in platelet aggregation: an emerging target for the prevention of acute coronary thrombotic occlusions | |
| DK0525252T3 (da) | Anvendelse af stafylokinase til fremstilling af en farmaceutisk sammensætning til behandling af arteriel thrombose. | |
| JPS5697226A (en) | Blood platelet coagulation inhibitor | |
| Pamboukian et al. | Management strategies for heparin-induced thrombocytopenia in heart-transplant candidates: case report and review of the literature | |
| Hirsh | introduction: Thrombosis | |
| Becker et al. | Evolution of direct thrombin antagonists: acknowledging potential limitations | |
| ATE265044T1 (de) | Verfahren und verbindungen zur beeinflussung von beta3-integrin-abhängigen intrazellulären prozessen | |
| MX9704594A (es) | Peptidos heterociclicos de la ceto-arginina, como inhibidores de la trombina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |